Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer. [electronic resource]
Producer: 20190227Description: 853-861.e4 p. digitalISSN:- 1878-3686
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Ipilimumab -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Nivolumab -- administration & dosage
- Small Cell Lung Carcinoma -- drug therapy
- Treatment Outcome
- Tumor Burden -- drug effects
- Exome Sequencing
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.